Dan Du
Impact in
-
- Traditional Chinese Medicine Analysis
- Molecular Biology top 10%
Papers in
- Surgery 26
- Pancreatitis Pathology and Treatment 24
-
- Metabolomics and Mass Spectrometry Studies 5
- Natural product bioactivities and synthesis 4
- Phytochemical Studies and Bioactivities 4
- Co-authors
- Qing Xia (25 shared papers)Jing Qu (11 shared papers)Meng Gong (6 shared papers)Shisheng Wang (5 shared papers)Shuang‐Gang Ma (8 shared papers)Yaohui Chen (2 shared papers)Shi‐Shan Yu (8 shared papers)Wen Li Zheng (4 shared papers)
- Journals
- Phytomedicine (6 papers)Analytical Chemistry (4 papers)Acta Pharmaceutica Sinica B (3 papers)Journal of Ethnopharmacology (3 papers)Journal of Natural Products (3 papers)
- Partner nations
- ChinaUnited KingdomNew Zealand
In The Last Decade
Dan Du
67 papers receiving 1.8k citations
Dan Du's Hit Papers
Peers
Comparison fields: 5 of 103
- Complementary and alternative medicine 111
- Molecular Biology 595
- Pharmacology 131
- Cardiology and Cardiovascular Medicine 202
- Infectious Diseases 139
Countries citing papers authored by Dan Du
This map shows the geographic impact of Dan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Du more than expected).
Fields of papers citing papers by Dan Du
This network shows the impact of papers produced by Dan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Du. The network helps show where Dan Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF Hit paper breakdown → | 2020 | 347 |
| 2 | 2020 | 121 | |
| 3 | 2010 | 96 | |
| 4 | 2020 | 80 | |
| 5 | 2020 | 61 | |
| 6 | 2014 | 56 | |
| 7 | 2010 | 50 | |
| 8 | 2009 | 46 | |
| 9 | 2018 | 46 | |
| 10 | 2013 | 43 | |
| 11 | 2022 | 43 | |
| 12 | 2022 | 41 | |
| 13 | 2012 | 34 | |
| 14 | 2012 | 33 | |
| 15 | 2018 | 31 | |
| 16 | 2021 | 31 | |
| 17 | 2021 | 31 | |
| 18 | 2021 | 31 | |
| 19 | 2019 | 30 | |
| 20 | 2010 | 29 |
About Dan Du
Dan Du is a scholar working on Surgery, Molecular Biology, Pharmacology, Complementary and alternative medicine and Pharmacology, having authored 70 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (24 papers), Phytochemistry and Biological Activities (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Natural product bioactivities and synthesis (4 papers), Traditional Chinese Medicine Analysis (4 papers), Phytochemical Studies and Bioactivities (4 papers), Plant chemical constituents analysis (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Complementary and alternative medicine (111 citations), Molecular Biology (595 citations), Pharmacology (131 citations), Cardiology and Cardiovascular Medicine (202 citations) and Infectious Diseases (139 citations). Dan Du has collaborated with scholars based in China, United Kingdom and New Zealand. Frequent co-authors include Qing Xia, Jing Qu, Meng Gong, Shisheng Wang, Shuang‐Gang Ma, Yaohui Chen, Shi‐Shan Yu, Wen Li Zheng, Chenxia Han and Wei Huang. Their work appears in journals such as Phytomedicine, Analytical Chemistry, Acta Pharmaceutica Sinica B, Journal of Ethnopharmacology and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.